Personalized Neoantigen Vaccines Boost Progress Against Aggressive Cancers
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.
Progress Against Cancer
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
Researchers are exploring new options for kidney cancer treatments.
Researchers are examining the gut microbiome to find better ways to diagnose and manage colorectal cancer.
February’s selections include a modified Zika virus to treat cancer, insights into treatment resistance, and more.
Researchers are finding early clinical success in developing more targeted treatments for bile duct cancer, also called cholangiocarcinoma.
January’s selections include disparities in genetic testing, updates from a breast cancer clinical trial, and more.
In part 4 of our 2024 Experts Forecast, Paul Workman, PhD, shares thoughts on cutting-edge advances in oncology drug...
In part 3 of our 2024 Experts Forecast, AACR President-Elect Patricia M. LoRusso, DO, PhD (hc), FAACR, shares thoughts...
January is Cervical Cancer Awareness Month. Here's the latest on prevention, screening, and treatment.